Hmmm, though not much excitement or volume. In the age of t-cell treatments etc, Bisantrene is kind of old school. Hopefully this trial in Israel can generate the sort of AML results achieved all those years ago.
Honestly, it's the low MC that's a large part of my attraction to this one, I'm just not sure how much it's swaying my judgement.
I never looked into how it dropped off the radar and got shelved. Can anyone give me a quick summary?
Cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $201.5M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.16 | $39.17K | 33.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3560 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 4359 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |